Physician
Radiation Oncology
David Gallardo is an expert in the field of Radiation Oncology. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine David Gallardo is a published physician. He published 16 publications, including: 'Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.' David Gallardo accepts all Medicare patients.
Publications
- Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
- Genetic variation at the goat hormone-sensitive lipase ( LIPE) gene and its association with milk yield and composition.
- [Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin''s lymphoma: study of...
- Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A c...
- Mapping of quantitative trait loci for cholesterol, LDL, HDL, and triglyceride serum concentrations in pigs.
- PCR-based methodology for molecular microchimerism detection and quantification.
- Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation.
- Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine.
- CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
- Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation.
- Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells...
- Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease.
- Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma.
- Outcome and toxicity of salvage treatment on patients relapsing after autologous hematopoietic stem cell transplantation--experience from a single center.
- Long-term disease-free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN-alpha.
Schools
University of California At Los Angeles
Conditions Treated
Doctors Specialties
Accepted Insurances
Education
-
VA Greater Los Angeles Healthcare System
-
David Geffen School of Medicine at UCLA
Drug Facts
| NPI NUMBER |
|
1114913282 |
| NPPES Provider LastName |
|
GALLARDO |
| NPPES Provider FirstName |
|
DAVID |
| NPPES Provider ZIPCode |
|
932747811 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Radiation Oncology |
| Total Claim Count |
|
63.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1114913282 |
| Last Name Of The Provider |
GALLARDO |
| First Name Of The Provider |
DAVID |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.